These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 768974)

  • 21. [Therapy of blood protein disorders].
    Wuhrmann F
    Clin Ter; 1970 May; 53(4):291-8. PubMed ID: 4990207
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of androgens and anabolic steroids in the treatment of cancer.
    Brodsky I
    Semin Drug Treat; 1973; 3(1):15-25. PubMed ID: 4740371
    [No Abstract]   [Full Text] [Related]  

  • 23. MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.
    Valeriote F; Grates H
    J Natl Cancer Inst; 1986 Jan; 76(1):61-5. PubMed ID: 3455743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development and current perspectives of treatment in multiple myeloma].
    Sanz Marca A; López Alvarez J; Aboin Massieu FJ
    Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon.
    Ali R; Ozkalemkas F; Ozkan A; Ozkocaman V; Ozcelik T; Ozan U; Kurt M; Tunali A
    Leuk Res; 2007 Aug; 31(8):1153-5. PubMed ID: 16945413
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal insufficiency and myeloma: therapeutic success in relation to reduction of tumor mass].
    Bondía Román A; San Miguel J; Guervos CS; Batlle F; Tabernero Romo JM; López-Borrasca A
    Rev Clin Esp; 1982 Feb; 164(3):191-2. PubMed ID: 7089337
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological and rheological disorders in multiple myeloma patients].
    Abdulkadyrov KM; Bessmel'tsev SS; Liubimova NIu
    Ter Arkh; 1991; 63(7):122-6. PubMed ID: 1788790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage therapy options for myeloma patients.
    Hussein MA;
    Oncology (Williston Park); 2004 Sep; 18(10):1233-5. PubMed ID: 15526828
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple myeloma in end-stage renal disease.
    Penfield JG
    Semin Dial; 2006; 19(4):329-34. PubMed ID: 16893412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasmapheresis and survival of patients with myeloma and secondary renal insufficiency].
    Notario A; Torriani A; Vitti MP; Fornasari PM; Zocchi MT; Doneda G
    Minerva Med; 1983 Dec; 74(47-48):2861-5. PubMed ID: 6657126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
    Bergner R; Hoffmann M; Uppenkamp M
    Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
    [No Abstract]   [Full Text] [Related]  

  • 33. Concurrent radiation therapy and lenalidomide in myeloma patient.
    Marchand V; Decaudin D; Servois V; Kirova YM
    Radiother Oncol; 2008 Apr; 87(1):152-3. PubMed ID: 18077032
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current aspects of treatment of multiple myeloma].
    Tribalto M; Avvisati G; Cantonetti M; Catalano G; Giovangrossi P; Masi M; Petrucci MT; Venditti A; Papa G
    Ann Ital Med Int; 1988; 3(3):193-202. PubMed ID: 3152856
    [No Abstract]   [Full Text] [Related]  

  • 35. Procarbazine (NSC-77213) and multiple myeloma.
    Moon JH; Edmonson JH
    Cancer Chemother Rep; 1970 Aug; 54(4):245-8. PubMed ID: 5527020
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
    Krejcí M; Doubek M; Adam Z; Hájek R; Vorlícek J; Mayer J
    Vnitr Lek; 1997 Nov; 43(11):756-8. PubMed ID: 9650509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Skeletal bone lesion and the effectiveness of Bonephos (clodronate) in the comprehensive therapy of multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Vopr Onkol; 1996; 42(4):12-8. PubMed ID: 8928450
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of multiple myeloma: melphalan--40 years old and still going strong.
    Bergsagel PL
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):2-3. PubMed ID: 12533738
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment and surveillance of multiple myeloma].
    Clauvel JP
    Rev Prat; 1978 Jun; 28(35):2729-33. PubMed ID: 675102
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal failure in multiple myeloma. Pathogenesis and prognostic implications.
    Alexanian R; Barlogie B; Dixon D
    Arch Intern Med; 1990 Aug; 150(8):1693-5. PubMed ID: 2383164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.